Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea

Fertil Steril. 1990 May;53(5):811-6. doi: 10.1016/s0015-0282(16)53514-6.

Abstract

The efficacy of a technique of gonadotropin suppression and human menopausal gonadotropins (hMG) to induce ovulation in women with hypergonadotropic amenorrhea was evaluated in 100 consecutive women. Ovulation was achieved in 19% of cycles (68/361), the pregnancy rate per cycle was 5.2% (19/361), and the viable pregnancy rate was 2.2% (8/361). In the majority of the successful cases, estrogen was used to decrease the elevated luteinizing hormone and follicle-stimulating hormone levels, especially where the ethinyl estradiol therapy alone induced a rise in endogenous 17 beta-estradiol levels with hMG used to boost the follicle to maturation. Although the success rate is low, this technique can result in some successes in otherwise almost hopeless cases.

MeSH terms

  • Adult
  • Amenorrhea / complications
  • Amenorrhea / physiopathology
  • Amenorrhea / therapy*
  • Estrogens / therapeutic use
  • Ethinyl Estradiol / therapeutic use
  • Female
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Gonadotropins / blood
  • Hormones / therapeutic use
  • Humans
  • Infertility / physiopathology
  • Infertility / therapy*
  • Leuprolide
  • Menotropins / therapeutic use
  • Middle Aged
  • Ovulation Induction*
  • Pregnancy Outcome
  • Pregnancy*
  • Time Factors

Substances

  • Estrogens
  • Gonadotropins
  • Hormones
  • Gonadotropin-Releasing Hormone
  • Ethinyl Estradiol
  • Menotropins
  • Leuprolide